Lepu COVID-19 Antigen Kit MSLDNA08

Novel Coronavirus (COVID-19) Lepu Antigen Detection Kit MSLDNA08 (Latex Immunochromatography )

SARS-CoV-2 Introduction
Since the outbreak of the novel coronavirus (COVID-19) at the end of 2019, the infected people have spread all over the world. The World Health Organization (WHO) announced that the disease caused by this virus was officially named COVID-19, and the International Commission for Classification of Viruses (ICTV) officially announced this new coronavirus. Named SARS-CoV-2, also known as 2019-nCoV, SARS-CoV-2 belongs to the β-coronavirus genus. 

The main functional receptor of SARS-CoV-2 is ACE2, and more importantly, SARS-CoV-2 The ability to combine with ACE2 is much higher than that of SARS virus, making SARS-CoV-2 gain a stronger transmission ability, which is a severe test for epidemic prevention and control and clinical medical treatment.

The Lepu COVID-19 Antigen Detection Kit MSLDNA08 method has obvious advantages in sensitivity and is a common detection method for new coronaviruses. Faced with the current situation of high contagion and large numbers of infected people, accurate and rapid detection will help epidemic prevention and control and medical treatment.

The lepu novel coronavirus (COVID-19) antigen detection kit MSLDNA08 is an in vitro test card for the determination of novel coronavirus in nasopharyngeal (NP) swab samples. This kit achieves the purpose of detection by combining the novel coronavirus (COVID-19) antigen and the novel coronavirus (COVID-19) antibody to form a reaction complex for color rendering. This product can quickly and accurately diagnose the novel coronavirus (COVID-19).

Lepu COVID-19 Antigen Detection Kit MSLDNA08  Advantage
1. This kit only takes 15-20 minutes to get the test results. 
2. The operations of this kit is simpler and faster, and the samples are easy to store. 
3. This kit can complete the test without additional reagents. 
4. This kit has the characteristics of high sensitivity and high accuracy. 
5. Makes up for the 7-14 day window period of new crown antibody detection

Lepu COVID-19 Antigen Detection Kit MSLDNA08  Product performance
1. Positive coincidence rate: Test 5 the novel coronavirus (COVID-19) recombinant antigen reference materials (P1~P5), and the results should all be positive. 
2. Negative coincidence rate: 5 copies of the novel coronavirus (COVID-19) recombinant antigen reference product (N1~N5) were tested, and the results should all be negative. 
3. Minimum detection limit: 3 copies of the novel coronavirus (COVID-19) recombinant antigen reference material (L1~L3) should be tested, L1 should be negative, L2 and L3 should be positive. 
4. Repeatability: Repeat the test of the novel coronavirus (COVID-19) recombinant antigen reference (R) 10 times, and the results should all be positive.